Immunovia AB (FRA:1YR)
€ 0.0338 0.0013 (4%) Market Cap: 8.99 Mil Enterprise Value: 6.59 Mil PE Ratio: 0 PB Ratio: 2.83 GF Score: 42/100

Immunovia AB (publ) - Special Call Transcript

Nov 03, 2020 / 08:00AM GMT
Julie Silber;publ;Director of IR
Immunovia AB

()-

Ladies and gentlemen, thank you for standing by, and welcome to the Immunovia webinar to introduce our new CEO, Patrik Dahlen. We will also take some time to further discuss the results from the verification study. (Operator Instructions) As a reminder, this webinar is being recorded. Joining us today from Immunovia are Board Chair, Carl Borrebaeck; and Patrik Dahlen, CEO.

Before we begin, a quick reminder to our listeners.

During today's webinar, management may make forward-looking statements involving known and unknown risks, uncertainties, other important factors beyond the company's control that could cause the company's actual results, performance or achievements to be materially different from the expected results, performance or achievements expressed or implied by such forward-looking statements.

These statements are subject to risks and uncertainties that could cause actual results to differ materially from those contained in the forward-looking statements. Actual results and the timing

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot